1. Division of Hematology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA;
2. Queensland Institute of Medical Research, Brisbane, Australia;
3. Klinik für Hämatologie und Onkologie, Otto-von-Guericke Universität, Magdeburg, Germany;
4. Division of Hematology/ Oncology, Children’s Hospital Boston and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and
5. University of Queensland, Brisbane, Australia